Obesity drug Wegovy reduces heart attacks and strokes risk by 20%, shows study
1 year, 4 months ago

Obesity drug Wegovy reduces heart attacks and strokes risk by 20%, shows study

Hindustan Times  

Novo Nordisk A/S shares surged to a record after the Danish company’s blockbuster obesity medicine Wegovy reduced the risk of heart attacks and strokes in a highly anticipated study, giving it another potential boost. Obesity drug Wegovy reduces heart attacks and strokes risk by 20%, shows study Patients with obesity or overweight and with a history of cardiovascular issues taking the Novo drug were 20% less likely to suffer a cardio event than those who took a placebo, the Danish drugmaker said on Tuesday. The study results will almost certainly bolster the already high demand for Novo’s medicine and may aid reimbursement discussions with insurers by documenting a health benefit beyond the effects of weight loss. Novo has been in the limelight after celebrities and key business executives said they were using its diabetes and obesity drugs, called Ozempic and Wegovy, to shed pounds.

Obesity Heart Attacks Drug Wegovy Novo  weight  attacks  strokes  shows  reduces  drug  medicines  patients  wegovy  heart  obesity  risk  novo  study

History of this topic

Consultations for obesity drug prescriptions are way up over 2023, survey finds
1 week, 5 days ago

Consultations for obesity drug prescriptions are way up over 2023, survey finds

NPR  

Consultations for obesity drug prescriptions are way up over 2023, survey finds Appointments with health professionals for obesity drug consultations are way up, according to data from Zocdoc, a provider of scheduling services. SYDNEY LUPKIN, BYLINE: Doctor Sarah Nosal, a family physician in the South Bronx, New York, says a lot more of her patients have come in asking about …

Eli Lilly new trial is all about the battle to be best weight-loss drug zepbound and wegovy
2 weeks, 5 days ago

Eli Lilly new trial is all about the battle to be best weight-loss drug zepbound and wegovy

India Today  

In a study trial, pharmaceutical giant Eli Lilly's weight-loss drug Zepbound showed better results than another pharmaceutical company, Novo Nordisk's weight-loss drug Wegovy. The trial, called SURMOUNT-5, compared Zepbound to Wegovy, which is a mono GLP-1 receptor agonist in adults living with obesity without diabetes. The results showed Zepbound delivering a remarkable 47% greater relative weight loss compared to Wegovy, …

Zepbound tops Wegovy for weight loss in Eli Lilly study
2 weeks, 5 days ago

Zepbound tops Wegovy for weight loss in Eli Lilly study

Associated Press  

Share Share Copy Link copied Email Facebook X Reddit LinkedIn Pinterest Flipboard Print Shares of Eli Lilly climbed Wednesday after the drugmaker detailed a study showing that its blockbuster weight-loss drug Zepbound helped patients shed more pounds than Wegovy from rival Novo Nordisk. Lilly said patients taking Zepbound lost about 20% of their weight on average compared to nearly 14% …

Eli Lilly’s Zepbound beats Novo Nordisk’s Wegovy in first head-to-head study
2 weeks, 5 days ago

Eli Lilly’s Zepbound beats Novo Nordisk’s Wegovy in first head-to-head study

Live Mint  

In the first head-to-head test, Eli Lilly’s Zepbound obesity drug helped people lose significantly more weight than its main competitor, Novo Nordisk’s Wegovy. The details People taking Zepbound lost 20.2% of their body weight on average after 72 weeks of treatment in the Lilly- That translated into an average 50-pound loss for people who took Zepbound, while Wegovy users lost …

Novo Nordisk India execs urge early Wegovy launch as weight-loss rival looms
2 weeks, 6 days ago

Novo Nordisk India execs urge early Wegovy launch as weight-loss rival looms

Live Mint  

* Novo Nordisk India team fears losing competitive edge to Eli Lilly * Novo's Wegovy and Lilly's Mounjaro are GLP-1 receptor agonists * India's obesity rates rising, increasing demand for weight-loss drugs By Leroy Leo and Rishika Sadam BENGALURU/HYDERABAD, Dec 3 - Novo Nordisk's team in India has been pushing the Danish drugmaker's global leadership for an earlier launch of …

Cheap Ozempic? Millions of obese Americans wait on Trump’s decision
3 weeks, 5 days ago

Cheap Ozempic? Millions of obese Americans wait on Trump’s decision

The Independent  

The latest headlines from our reporters across the US sent straight to your inbox each weekday Your briefing on the latest headlines from across the US Your briefing on the latest headlines from across the US SIGN UP I would like to be emailed about offers, events and updates from The Independent. The rule, unveiled on Tuesday by the Health …

Cheap Ozempic? How millions of Americans with obesity may get access to costly weight-loss drugs
Trending News
3 weeks, 6 days ago

Cheap Ozempic? How millions of Americans with obesity may get access to costly weight-loss drugs

Associated Press  

WASHINGTON — Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $ 35 billion proposal from the Biden administration is blessed by President-elect Donald Trump. The rule, unveiled Tuesday by the Health and Human Services Department, would require Medicare and Medicaid to cover weight-loss drugs like Wegovy or Zepbound …

Novo Nordisk’s Wegovy launches in China, offering obesity drug at a fraction of US prices
1 month ago

Novo Nordisk’s Wegovy launches in China, offering obesity drug at a fraction of US prices

Salon  

Semaglutide and tirzepatide medications have transformed weight loss, diabetes management, and overall health in recent years. According to Reuters and CNN, Novo Nordisk announced Monday that it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market, where more than 180 million people live with obesity. Eli Lilly, Novo Nordisk’s direct competitor and the manufacturer of …

Weight-loss drug Wegovy launched in China
1 month ago

Weight-loss drug Wegovy launched in China

CNN  

Novo Nordisk said Monday it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market where it estimates more than 180 million people live with obesity. Novo gained approval for Wegovy in China in June and will initially target Chinese patients willing to pay out-of-pocket for the weekly injectable drug. Strong sales there and in the …

Wegovy/Mounjaro: The UK thinks weight loss drugs could ease unemployment. Experts say that’s a fantasy
Trending News
1 month, 1 week ago

Wegovy/Mounjaro: The UK thinks weight loss drugs could ease unemployment. Experts say that’s a fantasy

CNN  

London CNN — Weight loss drugs such as Wegovy and Ozempic have been hailed worldwide as revolutionary for medicine. British Prime Minister Keir Starmer has said that his government needs to “think differently” about how to reduce pressure on the country’s national health care system, overburdened amid staffing shortages and funding pressures. Tom Little/Reuters The government trial studying links between …

Makers of Wegovy and Ozempic issue warning over deadly weight-loss copycats
Trending News
1 month, 2 weeks ago

Makers of Wegovy and Ozempic issue warning over deadly weight-loss copycats

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. Novo Nordisk’s popular weight-loss injection Wegovy and diabetes drug …

Obesity Pill Data Portend Competition, Hitting Drugmaker Shares
1 month, 2 weeks ago

Obesity Pill Data Portend Competition, Hitting Drugmaker Shares

Live Mint  

-- Obesity pill data released by Viking Therapeutics Inc. and AstraZeneca Plc at a big conference foreshadowed an increasingly competitive landscape for weight-loss therapies, sending down shares of drugmakers in the field. Effectiveness and safety data from Viking’s study, released Sunday at an industry conference, show that an obesity pill could be a reality soon: People who took 100-milligram doses …

Big Pharma’s obesity bonanza faces new tests
1 month, 2 weeks ago

Big Pharma’s obesity bonanza faces new tests

Live Mint  

In terms of recent stock-market frenzies, the Ozempic trade nearly tops the list, second only to speculation that artificial intelligence will soon be writing this column. Powerful weight-loss drugs like Wegovy and Zepbound have driven nearly $1 trillion in market-capitalization gains, with most of those gains flowing to Eli Lilly and Novo Nordisk, the dominant players in the obesity-drug market. …

Ozempic, Wegovy considered ‘available’ after more than 2 years in shortage
1 month, 3 weeks ago

Ozempic, Wegovy considered ‘available’ after more than 2 years in shortage

The Independent  

Sign up to our free Living Well email for advice on living a happier, healthier and longer life Live your life healthier and happier with our free weekly Living Well newsletter Live your life healthier and happier with our free weekly Living Well newsletter SIGN UP I would like to be emailed about offers, events and updates from The Independent. …

The US has passed peak obesity, a new survey suggests. Is it the Ozempic effect?
2 months, 2 weeks ago

The US has passed peak obesity, a new survey suggests. Is it the Ozempic effect?

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. Please try again later {{ /verifyErrors }} The United …

Wegovy weight loss: The science and the hype of supplements
2 months, 2 weeks ago

Wegovy weight loss: The science and the hype of supplements

The Hindu  

Published : Oct 04, 2024 18:39 IST - 5 MINS READ It was sometime during the COVID-19 pandemic when Wegovy and Ozempic hit mainstream awareness. When used as a weight loss medication, Wegovy is only recommended “as an adjunct to diet and exercise to reduce weight in patients who are very obese,” Ward told DW. But the side effects mean …

Ozempic and Wegovy can supercharge weight loss and even defy ageing – but can they save the NHS?
3 months, 3 weeks ago

Ozempic and Wegovy can supercharge weight loss and even defy ageing – but can they save the NHS?

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. Another piece of research from the same trial suggested …

Eli Lilly is gaining on Novo Nordisk in the obesity race
4 months, 2 weeks ago

Eli Lilly is gaining on Novo Nordisk in the obesity race

Live Mint  

The two companies’ divergent earnings reports this week showed that Indianapolis-based Lilly is moving faster than its Denmark-headquartered counterpart in the race to win the GLP-1 war. Less than a year after approval, Eli Lilly’s weekly prescription volume of Zepbound is about where Novo was with Wegovy volume more than two years in, according to JPMorgan data. And while all …

Wegovy: Ozempic sister drug to be sold in Australia within days
4 months, 3 weeks ago

Wegovy: Ozempic sister drug to be sold in Australia within days

Daily Mail  

A drug that mimics popular weight loss medicine Ozempic will be available in Australian pharmacies within days. Like Ozempic, the drug is administered through a once-weekly pen, however it contains a higher amount of the active ingredient and is used to manage chronic weight conditions, whereas Ozempic is only approved to manage type 2 diabetes. In May the Australian government …

Ozempic-producer Novo Nordisk on track for record spending on lobbying in 2024
4 months, 3 weeks ago

Ozempic-producer Novo Nordisk on track for record spending on lobbying in 2024

Raw Story  

This article originally appeared in OpenSecrets. Novo Nordisk — the pharmaceutical giant behind popular weight-loss drugs Ozempic and Wegovy — spent a record $3.2 million on lobbying in the first six months of 2024 as the Denmark-based company expanded its footprint in the United States. In 2017, after two years of clinical trials, the Food and Drug Administration approved Novo …

Don't insure use of Wegovy slimming drug, health institute says
5 months, 1 week ago

Don't insure use of Wegovy slimming drug, health institute says

Dutch News  

Slimming drug Wegovy should not be included in the basic insurance package because its long-term health benefits are unclear and it will also boost costs, the Dutch healthcare institute has said in recommendations to health minister Fleur Agema. Pharmaceutical company Novo Nordisk filed a request for Wegovy to be admitted to the basic insurance package last year. A majority of …

Don't insure use of Wegovy slimming drug, health institute says
5 months, 1 week ago

Don't insure use of Wegovy slimming drug, health institute says

Dutch News  

Slimming drug Wegovy should not be included in the basic insurance package because its long-term health benefits are unclear and it will also boost costs, the Dutch healthcare institute has said in recommendations to health minister Fleur Agema. Pharmaceutical company Novo Nordisk filed a request for Wegovy to be admitted to the basic insurance package last year. A majority of …

Weight-loss war heats up as Wegovy rival found to lead to faster and greater results
5 months, 1 week ago

Weight-loss war heats up as Wegovy rival found to lead to faster and greater results

The Independent  

Sign up to our free Living Well email for advice on living a happier, healthier and longer life Live your life healthier and happier with our free weekly Living Well newsletter Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. Please …

Study links popular weight loss drugs to rare blinding eye condition
5 months, 2 weeks ago

Study links popular weight loss drugs to rare blinding eye condition

Hindustan Times  

Popular weight loss drugs have been linked to an uncommon eye-blinding condition, according to a new study. Study links popular weight loss drugs to rare blinding eye condition Patients with diabetes or obesity are commonly prescribed weight loss drugs, such as Ozempic or Wegovy, containing the protein semaglutide, which helps manage blood sugar by promoting production of insulin. A team …

Wegovy weight-loss drug OK'd in China
5 months, 4 weeks ago

Wegovy weight-loss drug OK'd in China

China Daily  

FILE PHOTO: A view shows the logo of Novo Nordisk at the company's office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, March 8, 2024. Danish drugmaker Novo Nordisk said Tuesday that its injectable weight-loss drug Wegovy has been approved in China, where the proportion of overweight and obese adults reached almost 51 percent of the country's 1.4 billion people …

Wegovy weight-loss drug OK'd in China
5 months, 4 weeks ago

Wegovy weight-loss drug OK'd in China

China Daily  

By AI HEPING in New York | chinadaily.com.cn | Updated: 2024-06-26 14:54 FILE PHOTO: A view shows the logo of Novo Nordisk at the company's office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, March 8, 2024. Danish drugmaker Novo Nordisk said Tuesday that its injectable weight-loss drug Wegovy has been approved in China, where the proportion of overweight and …

So, you’ve lost weight using Wegovy. What happens next?
7 months, 2 weeks ago

So, you’ve lost weight using Wegovy. What happens next?

The Independent  

Sign up to our free Living Well email for advice on living a happier, healthier and longer life Live your life healthier and happier with our free weekly Living Well newsletter Live your life healthier and happier with our free weekly Living Well newsletter SIGN UP I would like to be emailed about offers, events and updates from The Independent. …

Wegovy: At least 25,000 people in the US are starting weight-loss drug each week, drugmaker says
7 months, 3 weeks ago

Wegovy: At least 25,000 people in the US are starting weight-loss drug each week, drugmaker says

CNN  

CNN — Drugmaker Novo Nordisk said it’s been increasing supply of its sought-after weight-loss drug Wegovy, with at least 25,000 people now starting to take the medicine each week in the United States. We’re talking about, many patients, chronic treatment.” Eli Lilly, Novo Nordisk’s biggest competitor, also said this week it expects supply to increase later this year. “While we …

So you’ve lost weight using Wegovy. Does that mean you can stop taking it?
7 months, 3 weeks ago

So you’ve lost weight using Wegovy. Does that mean you can stop taking it?

Associated Press  

Millions of Americans who have dropped pounds and boosted their health using popular obesity drugs like Wegovy are facing a new dilemma: What happens if they stop taking them? Others want to stop for holidays or special occasions — or just because they don’t want to take the weekly shots indefinitely, said Dr. Katherine Saunders, an obesity expert at Weill …

No link between Ozempic, Wegovy and suicide, EU drug regulators say
8 months, 1 week ago

No link between Ozempic, Wegovy and suicide, EU drug regulators say

Associated Press  

Drug regulators in Europe have found no evidence that popular diabetes and weight-loss drugs like Ozempic and Wegovy are linked to a higher risk of suicidal thoughts or actions. A federally funded U.S. study also found that people taking semaglutide, the medication in Ozempic and Wegovy, had a lower risk of suicidal thoughts than those taking older medications to treat …

Weight-loss drug Wegovy offers benefits for people with diabetes and common form of heart failure, study finds
8 months, 2 weeks ago

Weight-loss drug Wegovy offers benefits for people with diabetes and common form of heart failure, study finds

CNN  

CNN — The popular weight loss drug Wegovy seems to provide more health benefits for people who have diabetes and a common kind of heart failure than just helping take off the pounds, according to a new study. The study, published Saturday in the New England Journal of Medicine, showed how the drug helped people with Type 2 diabetes who …

Medicare can pay for obesity drugs like Wegovy in certain heart patients
9 months ago

Medicare can pay for obesity drugs like Wegovy in certain heart patients

Associated Press  

Medicare can pay for the popular weight-loss drug Wegovy — as long as the patients using it also have heart disease and need to reduce the risk of future heart attacks, strokes and other serious problems, federal officials said Thursday. Part D plans could begin covering the drug “some time this year,” said Tricia Neuman, a Medicare policy specialist at …

Medicare can pay for obesity drugs like Wegovy in certain heart patients
9 months ago

Medicare can pay for obesity drugs like Wegovy in certain heart patients

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy Medicare can pay for the …

Wegovy’s Newly Verified Heart Benefits Under Review by Medicare
9 months, 1 week ago

Wegovy’s Newly Verified Heart Benefits Under Review by Medicare

Live Mint  

-- Medicare may soon be required to cover the blockbuster weight-loss drug Wegovy for heart disease patients with obesity after US regulators approved an expanded label last week. But after the US Food and Drug Administration said Wegovy could be used to help prevent life-threatening cardiovascular events, it raises the question of whether Medicare prescription drug programs will now have …

Obesity drug Wegovy is approved to cut heart attack and stroke risk in overweight patients
9 months, 2 weeks ago

Obesity drug Wegovy is approved to cut heart attack and stroke risk in overweight patients

Associated Press  

The popular weight-loss drug Wegovy, which has helped millions of Americans shed pounds, can now be used to reduce the risk of stroke, heart attacks and other serious cardiovascular problems in patients who are overweight or who have obesity, federal regulators said Friday. The decision was based on the results of a study that found that Wegovy cut the risk …

Weight-loss drug Wegovy can be marketed for heart benefits after FDA label update
9 months, 2 weeks ago

Weight-loss drug Wegovy can be marketed for heart benefits after FDA label update

CNN  

CNN — Wegovy’s not just for weight loss anymore. The US Food and Drug Administration on Friday approved drugmaker Novo Nordisk’s application to add cardiovascular benefits to the medicine’s label, making it the first weight-loss drug to also be cleared to reduce the risk of heart attack, stroke or heart-related death in people at higher risk of these conditions. “Wegovy …

Drugs like Ozempic and Wegovy could boost the US economy by a trillion dollars in a few years, Goldman Sachs predicts
9 months, 3 weeks ago

Drugs like Ozempic and Wegovy could boost the US economy by a trillion dollars in a few years, Goldman Sachs predicts

CNN  

Washington, DC CNN — The US economy is set to reap considerable benefits from Americans taking popular medications used for weight loss, including Ozempic and Wegovy, Goldman Sachs analysts wrote in a recent research report. Goldman Sachs argues that since poor health unambiguously weighs on the economy, improving health outcomes due to GLP-1s could lower costs and boost productivity, shoring …

Novo Nordisk pays $25.8 million to promote its obesity drug
1 year ago

Novo Nordisk pays $25.8 million to promote its obesity drug

Live Mint  

During his address, Dr. Lee Kaplan urged fellow doctors to use their prescription pads to fight the obesity crisis, according to a report by Reuters on December 1. Dr. Kaplan, a leading U.S. weight-loss specialist, recommended turning to new weight-loss medicines like Novo Nordisk's Wegovy to reduce obesity. “We are going to have to use these medications,” he said at …

Obesity drug Wegovy cut risk of serious heart problems by 20%, study finds
1 year, 1 month ago

Obesity drug Wegovy cut risk of serious heart problems by 20%, study finds

Associated Press  

The popular weight-loss drug Wegovy reduced the risk of serious heart problems by 20% in a large, international study that experts say could change the way doctors treat certain heart patients. “It moves from a kind of therapy that reduces body weight to a therapy that reduces cardiovascular events,” said Dr. Michael Lincoff, the study’s lead author and a heart …

AstraZeneca joins obesity drug craze as it signs £1.6bn deal with Chinese medical group
1 year, 1 month ago

AstraZeneca joins obesity drug craze as it signs £1.6bn deal with Chinese medical group

Daily Mail  

AstraZeneca has entered the race to develop a weight-loss drug after striking a £1.6billion deal with a Chinese medical group. China deal: AstraZeneca boss Pascal Soriot said that the move into weight loss drugs follows 'enormous need around the world' Details emerged just hours after it was revealed that AstraZeneca is facing a multi-million-pound legal battle over claims the efficacy …

Supply problems and insurance issues make popular weight-loss drugs hard to get
1 year, 3 months ago

Supply problems and insurance issues make popular weight-loss drugs hard to get

Associated Press  

When she prescribes the popular weight-loss drug Wegovy, Dr. Angela Fitch sends patients on a quest she likens to “The Hunger Games.” They will have to call drugstores over several days to find one with the properly sized first dose. Supply problems and insurance complications have made it difficult for people to start — and stay on — Wegovy and …

How does Wegovy work? The ‘game changing’ weight loss drug beloved by Hollywood
1 year, 3 months ago

How does Wegovy work? The ‘game changing’ weight loss drug beloved by Hollywood

The Independent  

Sign up to our free Living Well email for advice on living a happier, healthier and longer life Live your life healthier and happier with our free weekly Living Well newsletter Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. Please …

Wegovy weight-loss jab to launch in the UK
1 year, 3 months ago

Wegovy weight-loss jab to launch in the UK

The Independent  

Get the free Morning Headlines email for news from our reporters across the world Sign up to our free Morning Headlines email Sign up to our free Morning Headlines email SIGN UP I would like to be emailed about offers, events and updates from The Independent. Wegovy manufacturer Novo Nordisk said it believes the launch of the drug in the …

The obesity drugs waiting to hit the market
1 year, 4 months ago

The obesity drugs waiting to hit the market

The Hindu  

Novo Nordisk said a large study had shown its highly effective obesity drug Wegovy also had a clear cardiovascular benefit, boosting the Danish drugmaker’s hopes of moving beyond Wegovy’s image as a lifestyle drug. The following is a list of companies targeting the next big blockbuster opportunity: Novo Nordisk said a large study had shown its highly effective obesity drug, …

Ozempic, weight-loss drugs probed over reports of suicidal thoughts
1 year, 5 months ago

Ozempic, weight-loss drugs probed over reports of suicidal thoughts

LA Times  

Novo Nordisk A/S’s weight-loss drugs, including the injectable drug Ozempic, are being investigated by regulators after they received reports of patients experiencing suicidal thoughts. Novo Nordisk A/S’s weight-loss medications are under investigation by the European Union’s drugs regulator after a small number of reports of suicidal risks were referred to the watchdog. The European Medicines Agency is looking at adverse …

When will Ozempic pills be available and where? How much will weight loss drug cost?
1 year, 5 months ago

When will Ozempic pills be available and where? How much will weight loss drug cost?

Daily Mail  

Ozempic and Wegovy have become two of the fastest-selling drugs ever, irrevocably changing the obesity treatment landscape - but there have been a couple of catches. Novo Nordisk, the Danish company behind Wegovy and Ozempic, as well as Indiana-based Eli Lilly and New York-based Pfizer, are vying to become the first company to introduce a highly effective, safe, and extremely …

No more needles? A daily pill may work as well as Wegovy shots to treat obesity
1 year, 5 months ago

No more needles? A daily pill may work as well as Wegovy shots to treat obesity

Associated Press  

What if treating obesity could be as easy as popping an effective pill? “If you ask people a random question, ‘Would you rather take a pill or an injection?’ People overwhelmingly prefer a pill,” said Dr. Daniel Bessesen, chief of endocrinology at Denver Health, who treats patients with obesity but was not involved in the new research. Another 16-month study …

Scientist behind Ozempic says drug can make life ‘so miserably boring’
1 year, 6 months ago

Scientist behind Ozempic says drug can make life ‘so miserably boring’

The Independent  

Sign up to our free Living Well email for advice on living a happier, healthier and longer life Live your life healthier and happier with our free weekly Living Well newsletter Live your life healthier and happier with our free weekly Living Well newsletter SIGN UP I would like to be emailed about offers, events and updates from The Independent. …

FDA warns against using off-brand versions of Ozempic, Wegovy for weight loss
1 year, 6 months ago

FDA warns against using off-brand versions of Ozempic, Wegovy for weight loss

The Independent  

Sign up to our free Living Well email for advice on living a happier, healthier and longer life Live your life healthier and happier with our free weekly Living Well newsletter Live your life healthier and happier with our free weekly Living Well newsletter SIGN UP I would like to be emailed about offers, events and updates from The Independent. …

Discover Related